Registry for treating chronic total occlusion of coronary arteries in Japan
Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts
This study is gathering information from patients in Japan who have had a specific heart procedure to treat blocked arteries, to see how to improve treatment for these cases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 19000 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Kurashiki Central Hospital Academic / other |
| Locations | 1 site (Kurashiki) |
| Trial ID | NCT01889459 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a consensus on treatment strategies for percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) of coronary arteries. It involves a registry of patients who have undergone PCI for CTO, specifically focusing on cases handled by certified operators in Japan. The study will collect and analyze data to improve understanding and outcomes of PCI procedures for CTO lesions.
Who should consider this trial
Good fit: Ideal candidates include patients eligible for PCI who have chronic total occlusion lesions with specific characteristics.
Not a fit: Patients who are deemed ineligible for PCI based on clinical judgment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment strategies for patients with chronic total occlusion, leading to better outcomes.
How similar studies have performed: While this study focuses on a specific registry approach, similar studies have shown success in improving treatment strategies for chronic total occlusion.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients eligible for PCI Patients who underwent PCI for CTO lesions that contain the following: 1. Thrombolysis in myocardial infarction trial (TIMI) 0 2. The occlusive period more than 3 months or unknown 3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft Exclusion Criteria: Patients ineligible for PCI judged in clinical practice
Where this trial is running
Kurashiki
- Kurashiki Central Hospital — Kurashiki, Japan (Recruiting)
Study contacts
- Study coordinator: Keiko Oka
- Email: cto.e.registry@gmail.com
- Phone: 81-86-422-0210
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.